Uterine Embolization

Global Hysterectomy Market to Surpass $700 Million by 2012 (PR Newswire via Yahoo! Finance)

10 Jul 2008

According to Millennium Research Group's Global Markets for Hysterectomy Alternatives 2008 report, which covers global endometrial ablation devices, uterine artery embolization devices, hysteroscopes, and endometrial resection devices, the global hysterectomy market will generate more than $700 million in 2012, primarily driven by expanding GEA procedure volumes.

BioSphere Medical Schedules Second Quarter 2008 Financial Results Release and Conference Call (Business Wire via Yahoo! Finance)

8 Jul 2008

ROCKLAND, Mass.----BioSphere Medical, Inc. , a medical device company that has pioneered the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors, and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy, today announced that it plans to issue its financial results for the second quarter ended June 30, 2008 on ...

New ways to treat fibroids (The Herald News)

25 Jun 2008

When a woman is told her symptoms are due to uterine fibroids, the diagnosis may be given with a recommended solution: hysterectomy.